New York Senate bill in Session 2025-2026.
Status: in_committee. Latest action: March 27, 2025.
Relates to capping cost sharing for antiviral COVID-19 therapeutics.
Requires insurance companies, medical expense indemnity corporations, hospital service corporations, health service corporations and medical assistance programs to provide coverage for prescribed antiviral therapeutics approved by the food and drug administration for the treatment of COVID-19 at no cost to the patient.
| Date | Event | Detail |
|---|---|---|
| 2025-03-27 | Introduced | Bill introduced |
| 2025-03-27 | Status | in_committee |
| 2025-03-27 | Latest Action | In Senate Committee |